Common Stock, Shares, Outstanding of Akebia Therapeutics, Inc. from 31 Dec 2013 to 30 Sep 2025

Taxonomy & unit
us-gaap: shares
Description
Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.
Summary
Akebia Therapeutics, Inc. quarterly Common Stock, Shares, Outstanding in shares history and change rate from 31 Dec 2013 to 30 Sep 2025.
  • Akebia Therapeutics, Inc. Common Stock, Shares, Outstanding for the quarter ending 30 Sep 2025 was 265,226,038, a 25% increase year-over-year.
Source SEC data
View on sec.gov
Common Stock, Shares, Outstanding, Quarterly (shares)
Common Stock, Shares, Outstanding, YoY Quarterly Change (%)

Akebia Therapeutics, Inc. Quarterly Common Stock, Shares, Outstanding (shares)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q3 2025 265,226,038 +53,683,916 +25% 30 Sep 2025 10-Q 10 Nov 2025 2025 Q3
Q2 2025 263,041,832 +53,112,687 +25% 30 Jun 2025 10-Q 07 Aug 2025 2025 Q2
Q1 2025 261,644,590 +52,190,441 +25% 31 Mar 2025 10-Q 08 May 2025 2025 Q1
Q4 2024 224,848,992 +30,266,453 +16% 31 Dec 2024 10-Q 10 Nov 2025 2025 Q3
Q3 2024 211,542,122 +23,228,315 +12% 30 Sep 2024 10-Q 07 Nov 2024 2024 Q3
Q2 2024 209,929,145 +21,800,276 +12% 30 Jun 2024 10-Q 08 Aug 2024 2024 Q2
Q1 2024 209,454,149 +23,618,203 +13% 31 Mar 2024 10-Q 09 May 2024 2024 Q1
Q4 2023 194,582,539 +10,446,825 +5.7% 31 Dec 2023 10-K 13 Mar 2025 2024 FY
Q3 2023 188,313,807 +4,362,224 +2.4% 30 Sep 2023 10-Q 08 Nov 2023 2023 Q3
Q2 2023 188,128,869 +4,424,215 +2.4% 30 Jun 2023 10-Q 28 Aug 2023 2023 Q2
Q1 2023 185,835,946 +2,449,911 +1.3% 31 Mar 2023 10-Q 08 May 2023 2023 Q1
Q4 2022 184,135,714 +7,134,751 +4% 31 Dec 2022 10-K 14 Mar 2024 2023 FY
Q3 2022 183,951,583 +9,399,594 +5.4% 30 Sep 2022 10-Q 03 Nov 2022 2022 Q3
Q2 2022 183,704,654 +14,053,231 +8.3% 30 Jun 2022 10-Q 04 Aug 2022 2022 Q2
Q1 2022 183,386,035 +24,865,946 +16% 31 Mar 2022 10-Q 09 May 2022 2022 Q1
Q4 2021 177,000,963 +28,926,878 +20% 31 Dec 2021 10-K/A 28 Aug 2023 2022 FY
Q3 2021 174,551,989 +31,223,337 +22% 30 Sep 2021 10-Q 04 Nov 2021 2021 Q3
Q2 2021 169,651,423 +26,522,014 +19% 30 Jun 2021 10-Q 05 Aug 2021 2021 Q2
Q1 2021 158,520,089 +28,268,649 +22% 31 Mar 2021 10-Q 10 May 2021 2021 Q1
Q4 2020 148,074,085 +26,399,517 +22% 31 Dec 2020 10-K 01 Mar 2022 2021 FY
Q3 2020 143,328,652 +24,464,917 +21% 30 Sep 2020 10-Q 05 Nov 2020 2020 Q3
Q2 2020 143,129,409 +24,342,108 +20% 30 Jun 2020 10-Q 10 Aug 2020 2020 Q2
Q1 2020 130,251,440 +13,129,178 +11% 31 Mar 2020 10-Q 05 May 2020 2020 Q1
Q4 2019 121,674,568 +4,787,050 +4.1% 31 Dec 2019 10-K 25 Feb 2021 2020 FY
Q3 2019 118,863,735 +61,817,172 +108% 30 Sep 2019 10-Q 12 Nov 2019 2019 Q3
Q2 2019 118,787,301 +61,873,415 +109% 30 Jun 2019 10-Q 08 Aug 2019 2019 Q2
Q1 2019 117,122,262 +60,264,792 +106% 31 Mar 2019 10-Q 09 May 2019 2019 Q1
Q4 2018 116,887,518 +69,274,899 +145% 31 Dec 2018 10-K 12 Mar 2020 2019 FY
Q3 2018 57,046,563 +9,808,562 +21% 30 Sep 2018 10-Q 08 Nov 2018 2018 Q3
Q2 2018 56,913,886 +14,422,929 +34% 30 Jun 2018 10-Q 08 Aug 2018 2018 Q2
Q1 2018 56,857,470 +18,027,908 +46% 31 Mar 2018 10-Q 09 May 2018 2018 Q1
Q4 2017 47,612,619 +8,996,910 +23% 31 Dec 2017 10-K 26 Mar 2019 2018 FY
Q3 2017 47,238,001 +8,984,811 +23% 30 Sep 2017 10-Q 08 Nov 2017 2017 Q3
Q2 2017 42,490,957 +4,482,024 +12% 30 Jun 2017 10-Q 08 Aug 2017 2017 Q2
Q1 2017 38,829,562 +883,552 +2.3% 31 Mar 2017 10-Q 09 May 2017 2017 Q1
Q4 2016 38,615,709 +7,953,491 +26% 31 Dec 2016 10-K 12 Mar 2018 2017 FY
Q3 2016 38,253,190 +8,035,096 +27% 30 Sep 2016 10-Q 09 Nov 2016 2016 Q3
Q2 2016 38,008,933 +9,126,403 +32% 30 Jun 2016 10-Q 08 Aug 2016 2016 Q2
Q1 2016 37,946,010 +17,472,386 +85% 31 Mar 2016 10-Q 05 May 2016 2016 Q1
Q4 2015 30,662,218 +10,291,594 +51% 31 Dec 2015 10-K 06 Mar 2017 2016 FY
Q3 2015 30,218,094 +9,917,851 +49% 30 Sep 2015 10-Q 09 Nov 2015 2015 Q3
Q2 2015 28,882,530 +8,619,552 +43% 30 Jun 2015 10-Q 11 Aug 2015 2015 Q2
Q1 2015 20,473,624 +210,931 +1% 31 Mar 2015 10-Q 11 May 2015 2015 Q1
Q4 2014 20,370,624 +18,987,279 +1373% 31 Dec 2014 10-K 14 Mar 2016 2015 FY
Q3 2014 20,300,243 30 Sep 2014 10-Q 10 Nov 2014 2014 Q3
Q2 2014 20,262,978 30 Jun 2014 10-Q 11 Aug 2014 2014 Q2
Q1 2014 20,262,693 31 Mar 2014 10-Q 12 May 2014 2014 Q1
Q4 2013 1,383,345 31 Dec 2013 10-K 04 Mar 2015 2014 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.